Jefferies' Cytokinetics (CYTK) Investor Survey Reveals Approval and Market Opportunity Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 62.91 +0.90 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.01 | 52 Week High | $13.18 | |||
| Open | $61.87 | 52 Week Low | $6.00 | |||
| Day High | $63.03 | P/E | N/A | |||
| Day Low | $61.59 | EPS | $-1.24 | |||
| Volume | 1,118,472 | |||||
